Cancer researchers are making strides in efforts to use genetic profiling to develop a more precise understanding of the response to treatment of acute myeloid leukemia (AML), a rare but aggressive blood cancer. In the most recent of a series of four studies featured in Bone Marrow Transplantation, researchers have found...